Josep Bassaganya-Riera, Landos Biopharma founder
March 1, 2023 07:14 AM EST
Deals
R&D

Ready to turn a new page, Lan­dos Bio­phar­ma of­floads for­mer lead pro­gram to founder

Amber Tong

Ear­li­er this year, au­toim­mune-fo­cused biotech Lan­dos Bio­phar­ma an­nounced that fol­low­ing a re­view of its pipeline, it will con­cen­trate on one of its clin­i­cal pro­grams and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: Am­gen obe­si­ty shot shows 20% weight loss, but dos­ing ques­tions hang over read­out

Up­dat­ed: Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

Alec­tor says Alzheimer's pro­gram tar­get­ing mi­croglia fails Phase 2, stock dives

Roche’s TIG­IT drug miss­es last shot at sur­vival end­point win in Phase 3 lung can­cer tri­al

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

A service from the Financial Times